Anaesthesia in the obese child

Claudia Philippi-Höhne1

  • 1University of Leipzig, Department of Anesthesiology and Intensive Care Medicine, Liebigstrasse 20, 04103 Leipzig, Germany. claudia.philippi-hoehne@medizin.uni-leipzig.de

Insights

Childhood obesity is rising globally, impacting paediatric anaesthesia. This review details obesity

Area of Science:

  • Pediatric Anesthesiology
  • Public Health
  • Pediatric Endocrinology

Background:

  • Childhood obesity incidence is increasing globally, affecting 8-17% of children.
  • Obesity presents significant challenges in pediatric anesthesia due to associated comorbidities.
  • Rising obesity rates necessitate a focus on anesthetic management and complication prevention in children.

Purpose of the Study:

  • To review the definition and epidemiology of childhood obesity.
  • To summarize potential comorbidities associated with pediatric obesity.
  • To provide guidance on preoperative evaluation, anesthetic management, and perioperative complication prevention.

Main Methods:

  • Literature review of current definitions and epidemiological data on childhood obesity.
  • Synthesis of information on obesity-related comorbidities in children.
  • Compilation of best practices for preoperative assessment, anesthesia, and postoperative care.

Main Results:

  • Childhood obesity is a growing global health concern with significant anesthetic implications.
  • Obese children have a higher prevalence of conditions like asthma and hypertension.
  • Increased risk of anesthesia-related complications is observed in obese pediatric patients.

Conclusions:

  • Effective preoperative evaluation and tailored anesthetic management are crucial for obese children.
  • Proactive strategies are needed to prevent perioperative complications in this population.
  • This review offers a comprehensive guide for clinicians managing anesthesia in pediatric obesity.

Related Concept Videos

Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy01:26

Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy

Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...